Growing insurer restrictions limit GLP-1 coverage: GoodRx
Commercial insurance coverage of blockbuster GLP-1 drugs has not expanded much over the past year, despite growing demand and expanded indications, according to a new report from GoodRx.
This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.